Chhattisgarh's Food and Drug Administration found three substandard drug samples from various districts after inspections and ...

Raipur: Three drug samples collected from various districts in Chhattisgarh were declared substandard following inspections ...

OneSource Specialty Pharma partners with Xbrane Biopharma for biosimilar manufacturing, aiming to strengthen global supply ...

OneSource Specialty Pharma and Xbrane Biopharma AB, a Sweden-headquartered biotechnology company, today announced a partnership focused on the commercial manufacturing of Xbrane's biosimilar portfolio ...

WuXi Biologics & Virogen Biotechnology establish commercial manufacturing partnership: Chengdu Tuesday, June 10, 2025, 17:00 Hrs [IST] WuXi Biologics, a leading global contract re ...

Gov. Gavin Newsom and Attorney General Rob Bonta filed an emergency request to block expansion of what they called the Trump ...

The Jammu Province Bachao Manch (JBM) has voiced deep concern over the worsening public issues in the region, particularly ...

Biontech SE and Bristol Myers Squibb Co. are teaming up to develop Biontech’s bispecific antibody targeting PD-L1 and VEGF-A, BNT-327, in a deal possibly worth over $11 billion. The companies will ...

Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a ...

Onesource Specialty Pharma advanced 1.55% to Rs 2057 after the company announced a partnership with Sweden-based Xbrane Biopharma AB for manufacturing biosimilars for global markets.

in accordance with US Food and Drug Administration manufacturing requirements. Given that safety is a primary consideration when administering CO to a patient, the Covox DS has multiple design ...